Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
3.430
-0.060 (-1.72%)
Jul 18, 2025, 1:45 PM CST

Hunan Er-Kang Pharmaceutical Company Description

Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.

Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol.

The company’s finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets.

Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products.

Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.

Hunan Er-Kang Pharmaceutical Co., Ltd
CountryChina
Founded2003
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,453
CEOQingrong Sun

Contact Details

Address:
No. 167
Changsha, Hunan Province 410331
China
Phone86 731 8465 9108
Websitehnerkang.com

Stock Details

Ticker Symbol300267
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100001781
SIC Code2834

Key Executives

NamePosition
Qingrong SunGM and Non-Independent Director
Zhao XunChief Financial Officer and Non Independent Director
Xiangyang ShiDeputy GM and Non Independent Director
Jishun GuDeputy GM and Board Secretary
Licheng ZhangDeputy General Manager
Yuhua KuangAccounting Supervisor